A rating of 61 puts Talaris Therapeutics Inc (TALS) near the middle of the Biotechnology industry according to InvestorsObserver. Talaris Therapeutics Inc's score of 61 means it scores higher than 61% of stocks in the industry. Talaris Therapeutics Inc also received an overall rating of 47, putting it above 47% of all stocks. Biotechnology is ranked 70 out of the 148 industries.
TALS has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TALS!